News and Press
Meeting Report for Synthetic Biology for Natural Products 2017
Optologix Selected For Start-Up Stadium At The 2017 BIO Convention
Optologix Attends International Society For Stem Cell Research (ISSCR) Annual Meeting
Discussion Panel On Drug Development At CUNY's Graduate Center Includes Optologix
New Study In Development Journal Demonstrates Applications Of LITE Switch System In The Zebrafish
Optologix's Laura Motta-Mena Presents At 2016 Health Wildcatters Pitch Day At The Majestic Theater
Laura Motta-Mena, CEO Of Optologix, To Speak At Synthetic Biology For Natural Products Conference
Neuroscience Annual Conference
2016 Pitch Day Health Wildcatters
Optologix In The Media September 2016
Optologix Selected To Join Startup Accelerator Health Wildcatters
Optologix Announces New Distributor In Japan
Optologix Is Selected To Participate In NewYorkBIO Pitch Fest 2016
Optologix And enEvolv Announce License Agreement
Optologix Announces License Agreement With UT Southwestern Medical Center
Nature Journal Interviews Dr. Gardner For Technology Feature On Optogenetics In Cell Biology
Dr. Gardner, CSO Of Optologix, Is Interviewed By ASBMB Today
Optologix Is Selected To Participate In ELabNYC 2015
An Optogenetic Gene Expression System Based On EL222
Optologix Selected For Start-Up Stadium At The 2017 BIO Convention
Optologix Attends International Society For Stem Cell Research (ISSCR) Annual Meeting
Discussion Panel On Drug Development At CUNY's Graduate Center Includes Optologix
New Study In Development Journal Demonstrates Applications Of LITE Switch System In The Zebrafish
Optologix's Laura Motta-Mena Presents At 2016 Health Wildcatters Pitch Day At The Majestic Theater
Laura Motta-Mena, CEO Of Optologix, To Speak At Synthetic Biology For Natural Products Conference
Neuroscience Annual Conference
2016 Pitch Day Health Wildcatters
Optologix In The Media September 2016
Optologix Selected To Join Startup Accelerator Health Wildcatters
Optologix Announces New Distributor In Japan
Optologix Is Selected To Participate In NewYorkBIO Pitch Fest 2016
Optologix And enEvolv Announce License Agreement
Optologix Announces License Agreement With UT Southwestern Medical Center
Nature Journal Interviews Dr. Gardner For Technology Feature On Optogenetics In Cell Biology
Dr. Gardner, CSO Of Optologix, Is Interviewed By ASBMB Today
Optologix Is Selected To Participate In ELabNYC 2015
An Optogenetic Gene Expression System Based On EL222
